Balanced news tone
News Sentiment
RMD sentiment intelligence
ResMed Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
27 relevant articles
News tone and price action are not far from neutral.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-3.8% over one week, -9.2% over four weeks, trend inactive, and near fair-value range.
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
90/100 classification
One-week reaction
-3.8%
Price reacting lower
Trend fit
Trend inactive
-9.2% over four weeks
Fair value
-19.4%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
17
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative?
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 22 Jun 2026 16:32
- Source
- simplywall.st
Moomoo
Direct company coverage
KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Announces Target Price $266
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 22 Jun 2026 07:03
- Source
- Moomoo
simplywall.st
Direct company coverage
ResMed (RMD) Stock Could Be 30.3% Undervalued After Morgan Stanley Downgrade
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 19 Jun 2026 07:38
- Source
- simplywall.st
GuruFocus
Direct company coverage
ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 22:53
- Source
- GuruFocus
StockStory
Direct company coverage
Why ResMed (RMD) Shares Are Falling Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:24
- Source
- StockStory
Seeking Alpha
Direct company coverage
ResMed stock downgraded at Morgan Stanley (RMD:NYSE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 12:49
- Source
- Seeking Alpha
Market source
Direct company coverage
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
ResMed (RMD) Stock After 21% Year-To-Date Slide Is There An Opportunity Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Market source
Trefis
Direct company coverage
ResMed Stock Delivers Strong Cash Yield – Upside Ahead?
- Tone
- Positive 82/100
- Event
- Balance sheet
- Published
- 02 Jun 2026 07:00
- Source
- Trefis
Quiver Quantitative
Direct company coverage
ResMed (RMD) slides as shares hit a 52-week low amid renewed post-earnings scrutiny | RMD Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Quiver Quantitative
The Motley Fool Australia
Direct company coverage
Buy, hold, sell: ResMed, Sigma, and TechnologyOne shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Why are Resmed shares lagging if the business keeps compounding?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Should you buy ResMed shares at their 52-week low?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- The Motley Fool Australia
TIKR.com
Direct company coverage
ResMed Stock Is Down 22% in 2026: Here’s Why Analysts Still Sees $256 Fair Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- TIKR.com
Market source
Direct company coverage
Why ResMed (RMD) Narrative Is Shifting As Analysts Reassess Growth And Valuation Assumptions
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
The Motley Fool Australia
Direct company coverage
What's going on with ResMed shares today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- The Motley Fool Australia
Market source
Direct company coverage
Is It Time To Reassess ResMed (RMD) After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2026 07:00
- Source
- Market source
The Motley Fool Australia
Direct company coverage
Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
With global populations ageing, are ResMed shares a good buy today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- The Motley Fool Australia
Market source
Direct company coverage
ResMed (RMD) Stock Trades Down, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Market source
The Motley Fool Australia
Direct company coverage
What can investors expect from ResMed, Cochlear and CSL shares this reporting season?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Why Morgans just upgraded ResMed shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Buy, hold, sell: Endeavour, ResMed, and Westpac shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Nov 2025 08:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Why is the ResMed share price down 4.9% today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Nov 2025 08:00
- Source
- The Motley Fool Australia